文献速递心血管MRUS

主动脉瓣狭窄中的弥漫性心肌纤维化与舒张功能

Diffuse Myocardial Fibrosis and Diastolic Function in Aortic Stenosis.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-08-19

本研究纳入191例中重度主动脉瓣狭窄患者和30例无心血管危险因素的对照者,行心脏磁共振检查。细胞外容积分数(ECV)越高,左心室舒张功能障碍(LVDD)患病率越高;ECV与间隔部e'降低及E/e'升高相关,且ECV和舒张功能参数共同解释呼吸困难与临床结局。

要点

  • 中重度主动脉瓣狭窄患者ECV越高,LVDD患病率越高,且与间隔部e'<7 cm/s及E/e'≥15相关。
  • 相同LVDD分级下,ECV更高的患者呼吸困难程度更重。
  • ECV升高、间隔部e'降低及E/间隔部e'升高均为临床事件的独立预测因素,ECV在临床因素及左室收缩、舒张功能之上提供增量预后价值。

核心结论

  • 心脏磁共振ECV评估的弥漫性心肌纤维化与主动脉瓣狭窄患者的LVDD相关,但ECV和左室舒张功能参数对呼吸困难和临床结局提供互补解释。
  • 联合评估LVDD和弥漫性心肌纤维化可能进一步识别症状更重、预后更差的主动脉瓣狭窄患者。

研究设计与样本

  • 研究纳入191例中度或重度主动脉瓣狭窄患者(平均年龄68.4岁)和30例无心血管危险因素的对照者,均行心脏磁共振检查。
  • 左室舒张功能障碍分级采用超声心动图按2016年美国超声心动图学会/欧洲心血管影像协会指南评估。
  • 临床结局定义为全因死亡或心力衰竭加重住院的复合终点。

诊断标准与关键数值

  • ECV五分位越高,LVDD患病率越高。
  • 较高ECV尤其与心肌松弛减弱(间隔部e'<7 cm/s)和左室充盈压升高(E/e'比值≥15)相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to investigate the relationship between extracellular volume fraction (ECV), a noninvasive parameter that quantifies the degree of diffuse myocardial fibrosis on cardiac magnetic resonance (CMR), and left ventricular diastolic dysfunction (LVDD) in patients with aortic stenosis (AS).

BACKGROUND: Myocardial fibrosis on invasive myocardial biopsy is associated with LVDD. However, there is a paucity of data on the association between noninvasively quantified diffuse myocardial fibrosis and the degree of LVDD and how these are related to symptoms and long-term prognosis in patients with AS.

METHODS: Patients with moderate or severe AS (n = 191; mean age 68.4 years) and 30 control subjects without cardiovascular risk factors underwent CMR. LVDD grade was evaluated using echocardiography according to the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging guidelines. Clinical outcomes were defined as a composite of all-cause mortality or hospitalization for heart failure aggravation.

RESULTS: Patients in higher ECV quintiles had a significantly higher prevalence of LVDD. Higher ECV was particularly associated with decreased myocardial relaxation (septal e' <7 cm/s) and increased LV filling pressure (E/e' ratio ≥15). Although both impaired diastolic function and higher ECV were significantly associated with a worse degree of dyspnea, patients with higher ECV showed greater dyspnea within the same grade of LVDD. During a median follow-up period of 5.6 years, 37 clinical events occurred. Increased ECV, as well as lower septal e' and higher E/septal e' ratio, were independent predictors of clinical events, irrespective of age, AS severity, aortic valve replacement, and left ventricular (LV) ejection fraction. ECV provided incremental prognostic value on top of clinical factors and LV systolic and diastolic function.

CONCLUSIONS: Diffuse myocardial fibrosis, assessed using ECV on CMR, was associated with LVDD in patients with AS, but both ECV and LV diastolic function parameters provided a complementary explanation for dyspnea and clinical outcomes. Concomitant assessment of both LVDD and diffuse myocardial fibrosis may further identify patients with AS with greater symptoms and worse prognosis.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Lee HJ, Lee H, Kim SM, et al. Diffuse Myocardial Fibrosis and Diastolic Function in Aortic Stenosis. JACC Cardiovasc Imaging. 2020. PMID: 32828787. doi:10.1016/j.jcmg.2020.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。